ZTS vs. BMY, PFE, ABBV, GSK, REGN, VRTX, TAK, SNY, GMAB, and ABT
Should you be buying Zoetis stock or one of its competitors? The main competitors of Zoetis include Bristol-Myers Squibb (BMY), Pfizer (PFE), AbbVie (ABBV), GSK (GSK), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Takeda Pharmaceutical (TAK), Sanofi (SNY), Genmab A/S (GMAB), and Abbott Laboratories (ABT). These companies are all part of the "pharmaceutical preparations" industry.
Bristol-Myers Squibb (NYSE:BMY) and Zoetis (NYSE:ZTS) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk, community ranking, media sentiment and dividends.
76.4% of Bristol-Myers Squibb shares are held by institutional investors. Comparatively, 92.8% of Zoetis shares are held by institutional investors. 0.1% of Bristol-Myers Squibb shares are held by insiders. Comparatively, 0.2% of Zoetis shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Bristol-Myers Squibb pays an annual dividend of $2.40 per share and has a dividend yield of 5.5%. Zoetis pays an annual dividend of $1.73 per share and has a dividend yield of 1.0%. Bristol-Myers Squibb pays out -77.4% of its earnings in the form of a dividend. Zoetis pays out 33.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Bristol-Myers Squibb has increased its dividend for 16 consecutive years and Zoetis has increased its dividend for 13 consecutive years. Bristol-Myers Squibb is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
In the previous week, Bristol-Myers Squibb had 17 more articles in the media than Zoetis. MarketBeat recorded 32 mentions for Bristol-Myers Squibb and 15 mentions for Zoetis. Zoetis' average media sentiment score of 0.70 beat Bristol-Myers Squibb's score of 0.62 indicating that Bristol-Myers Squibb is being referred to more favorably in the media.
Bristol-Myers Squibb currently has a consensus price target of $60.00, suggesting a potential upside of 36.27%. Zoetis has a consensus price target of $211.75, suggesting a potential upside of 21.65%. Given Zoetis' higher probable upside, analysts clearly believe Bristol-Myers Squibb is more favorable than Zoetis.
Bristol-Myers Squibb received 180 more outperform votes than Zoetis when rated by MarketBeat users. However, 77.82% of users gave Zoetis an outperform vote while only 66.87% of users gave Bristol-Myers Squibb an outperform vote.
Bristol-Myers Squibb has higher revenue and earnings than Zoetis. Bristol-Myers Squibb is trading at a lower price-to-earnings ratio than Zoetis, indicating that it is currently the more affordable of the two stocks.
Bristol-Myers Squibb has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500. Comparatively, Zoetis has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500.
Zoetis has a net margin of 27.38% compared to Zoetis' net margin of -13.50%. Bristol-Myers Squibb's return on equity of 50.34% beat Zoetis' return on equity.
Summary
Zoetis beats Bristol-Myers Squibb on 12 of the 21 factors compared between the two stocks.
Get Zoetis News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZTS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ZTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
